Table 2.
Overview of adverse events related with esophageal stent placement for different indications
| Indication | |||
|---|---|---|---|
| Malignant dysphagia10 n = 1017 | Benign dysphagia41 n = 232 | Esophageal leakage41 n = 599 | |
| Serious adverse event (%) | |||
| Major bleeding | 8.0 | 3.0 | 1.3 |
| Aspiration pneumonia | 5.0 | 1.3 | 0.7 |
| Perforation | 2.0 | 1.3 | 1.0 |
| Adverse events (%) | |||
| Retrosternal pain | 30.0 | 4.3 | 0.5 |
| Reflux symptoms | 7.0 | 2.6 | 0.5 |
| Recurrent dysphagia Cause: | 31.0 | 29.0 | 20.0 |
| Stent migration | 11.0 | 24.5 | 16.5 |
| Tissue in-/overgrowth | 14.0 | 2.2 | 2.7 |
| Food obstruction | 7.0 | 2.2 | 1.1 |
n number of patients, % percentage; 10 retrospective cohort analysis; 41 systematic review and pooled meta-analysis